Alternatively, high-activity ERAP1 present in patients with TT and, at lower level, with CT genotypes might destroy (by over-trimming) some cancer epitopes, and therefore the efficient cancer elimination by immune cells was impaired. The gene discussed is ERAP1; the disease is cancer.